Ameritas Advisory Services’s GSK GSK Stock Holding History

Ameritas Advisory Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$677K	Buy	12,918 +3,611	+39%	+$191K	0.01%	687
2026 Q1	$514K	Sell	9,307 -337	-3%	-$18.3K	0.02%	568
2025 Q4	$473K	Sell	9,644 -4,686	-33%	-$219K	0.02%	586
2025 Q3	$618K	Buy	14,330 +7,143	+99%	+$279K	0.04%	340
2025 Q2	$276K	Sell	7,187 -9,860	-58%	-$377K	0.01%	649
2025 Q1	$581K	Sell	17,047 -17,908	-51%	-$656K	0.02%	534
2024 Q4	$1.18M	Buy	34,955 +5,668	+19%	+$204K	0.04%	370
2024 Q3	$1.2M	Sell	29,287 -7,908	-21%	-$324K	0.05%	343
2024 Q2	$1.43M	Sell	37,195 -68	-0.2%	-$2.86K	0.05%	322
2024 Q1	$1.61M	Buy	37,263 +9,488	+34%	+$391K	0.07%	274
2023 Q4	$1.06M	Sell	27,775 -12,734	-31%	-$457K	0.06%	274
2023 Q3	$1.47M	Buy	40,509 +23,690	+141%	+$841K	0.07%	254
2023 Q2	$569K	Sell	16,819 -19,575	-54%	-$702K	0.07%	264
2023 Q1	$1.32M	Sell	36,394 -12,053	-25%	-$422K	0.07%	268
2022 Q4	$1.7M	Buy	+48,447	New	+$1.61M	0.08%	245
2022 Q3	–	Sell	-11,961	Closed	-$651K	–	782
2022 Q2	$651K	Sell	11,961 -862	-7%	-$47.6K	0.04%	391
2022 Q1	$698K	Buy	12,823 +778	+6%	+$42.3K	0.03%	421
2021 Q4	$664K	Buy	+12,045	New	+$627K	0.02%	429

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ameritas Advisory Services's GSK Position: Q2 2026 in Review

Ameritas Advisory Services increased its GSK (GSK) stake by 39% in Q2 2026, buying an estimated $191K and bringing the position to 12,918 shares worth $677K. The position accounts for 0.01% of the portfolio, ranked #687.

Ameritas Advisory Services first reported a position in GSK in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.7M in Q4 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Ameritas Advisory Services held 12,918 shares of GSK worth $677K as of Q2 2026.
Ameritas Advisory Services bought 3,611 GSK shares in Q2 2026, an estimated $191K.
GSK made up 0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #687 holding.
Ameritas Advisory Services first reported a position in GSK in Q4 2021 and has held it in 18 quarters since.
Ameritas Advisory Services's GSK position peaked at $1.7M in Q4 2022.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.